BioSpace News Archive

Deals

AEON Biopharma to Become Publicly Listed via Merger with Priveterra Acquisition Corp.; Accelerating Clinical Development of ABP-450 (prabotulinumtoxinA) Injection to Treat Debilitating Medical Conditions in Neurology

AEON Biopharma, Inc. and Priveterra Acquisition Corp. announced that they have entered into a definitive business combination agreement.

December 13, 2022
·
11 min read
Biotech Bay

Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)-- Patents support Gritstone’s pioneering work in the application of next-generation samRNA vaccine technology in oncology and infectious disease --

Gritstone bio, Inc. today announced that the United States Patent and Trademark Office (USPTO) recently issued two new patents related to the company’s novel self-amplifying mRNA (samRNA) vaccine platform technology.

December 13, 2022
·
5 min read
Lone Star Bio

Marker Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million

Marker Therapeutics, Inc. today announced that the Company has entered into a Common Stock Purchase Agreement (the “Agreement”) for up to $25 million with Lincoln Park Capital Fund (“LPC”).

December 13, 2022
·
5 min read
Deals

Cytokinetics Stock Trading Halted Today

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Nasdaq has halted the trading of the Company’s common stock.

December 13, 2022
·
8 min read
Genetown

Flagship Pioneering Unveils Montai Health to Treat and Preempt Chronic Disease Afflicting Two Billion People Worldwide

Flagship Pioneering, the bioplatform innovation company, unveiled Montai Health, a company unlocking the power of nature with its CONECTA™ platform to create medicines that treat and preempt a broad range of chronic diseases.

December 13, 2022
·
4 min read
FDA

Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops

Bausch + Lomb Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Biotrue Hydration Boost Contact Lens Rehydrating drops, a preservative-free multi-dose rehydrating drop for use with soft and rigid gas permeable contact lenses.

December 13, 2022
·
4 min read
Business

Empyrean Neuroscience Forms Scientific Advisory Board

Empyrean Neuroscience, Inc. today announced its scientific advisory board.

December 13, 2022
·
4 min read
Business

No Opioids After Surgery: Evonik Invests in Allay Therapeutics and Supplies Key Technology for Pain Therapy Implants

Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks.

December 13, 2022
·
5 min read
BioMidwest

Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program

Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program.

December 13, 2022
·
3 min read
Biotech Beach

Masimo Hosts Investor Day to Detail Next Phase of Its Growth Trajectory

Masimo Corporation (Nasdaq: MASI) (“Masimo” or the “Company”) will host its Investor Day today.

December 13, 2022
·
8 min read